What If Your Employer Only Covers GLP-1s for Diabetes Now
Marconi Monteiro , University of Texas Medical Branch, Galveston, Texas, United States Global Pediatric Innovation Scholars Program: Supporting Bidirectional Learning Christiana Russ , Boston Children's Hospital Boston, MA, United States Bridging Boundaries: The Impact of Peer Mentorship on the Integration, Socialization and Well-being of Refugee Students in Community Settings Carter Magnano , JaxTHRIVE, Inc, Ponte Vedra Beach, FL, United States Enhancing Workforce Diversity for Global Health Equity Kofi Kondwani , Morehouse School of Medicine, Atlanta, GA, United States Effectiveness of Training Residents as Teachers and Leaders for Health Systems Strengthening in Liberia Marie Martin , Vanderbilt University Nashville, TN, United States Martin Mutonga Yale School of Medicine Sonia Brockington Deakin University Megan Gauger University of Michigan F
Persistent, severe, or worsening symptoms need medical review
Diabetologia 52 , 882890 (2009)
Headaches are among the commonly reported side effects during the initial treatment phase, with frequency varying between different GLP-1 medicines according to their Summary of Product Characteristics